Join our Mission to Protect Humankind!
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, periodontitis and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.
Summary:
We are currently seeking an enthusiastic and self-motivated Senior Financial Analyst to join the FP&A team at Vaxcyte. This highly visible role will report to the Associate Director, FP&A and partner closely with R&D business partners including CMC and Manufacturing & Supply Chain. This position is primarily focused on supporting our day-to-day planning and budgeting activities of R&D. This is a newly created role to accommodate the growing organization. This position is ideal for a candidate with a background in Finance looking to develop skillsets in financial and strategic analysis, as you will be working closely with the Associate Director, FP&A to build budgets, processes and reporting dashboards. This position will also partner with other members of the FP&A team, including the Sr. Director of FP&A, on Clinical and other R&D related activities. The candidate should prioritize business partnerships, be innovative in creating solutions, and streamlining data reporting. The position will be hybrid based in the San Carlos, CA headquarters.
Essential Functions:
- Support the budgeting and forecasting, financial planning & analysis, and resource management process for R&D.
- Provide financial insights to help improve decision making and execution of business strategy.
- Establish strong partnerships and build trust with our R&D partners including CMC and manufacturing & supply chain business partners.
- Collaborate with Cost Accounting to ensure COGS optimization and provide appropriate visibility to Manufacturing / Supply Chain leadership.
- Support R&D pipeline modeling, including forecasts, and long-range plans.
- Support Budget vs. Actuals process for R&D.
- Assist in the preparation and administration of the Company’s annual budget, quarterly forecasts, and long-range planning processes.
- Assist with REQ & PO approval and tracking procedures.
- Assist with Anaplan Budget tool maintenance and enhancement.
- Consolidate clinical trial budgets and provide dashboards to leadership.
- Prepare executive level presentations for the forecast, budget, and long-range plan.
- Support other company initiatives which require cash projections, such as treasury activities, foreign currency risk management programs, cash budget vs actual analysis, and other ad hoc analysis.
- Support Accounting team with analyses for accruals and SOX requirements.
- Other responsibilities as assigned to support the company’s growth.
Requirements:
- Bachelor’s degree in Business Administration or equivalent is required; MBA, CPA, CFA or equivalent designation, is preferred.
- 4+ years of work experience in FP&A or related discipline.
- Experience in biotech / pharma finance with experience in R&D and/or Manufacturing a plus.
- Proven track record of supporting financial processes, including budgeting and forecasting.
- Works with a customer first mindset with the ability to effectively summarize and communicate business critical needs to business partners.
- Strong analytical, modeling skills, and experience with financial systems.
- Excellent communication, presentation, and organizational skills.
- Ability to thrive in a dynamic and fast-paced environment with the ability to think strategically and adapt quickly.
- Positive work ethic and organizational skills with a high attention to detail.
- An exceptional team player with focus on ensuring team meets and/ or exceeds deadlines and ability to partner with internal and external contacts at all levels.
Reports to: Associate Director of Financial Planning & Analysis
Location: San Carlos, CA
Compensation:
The compensation package will be competitive and includes comprehensive benefits and an equity component.
Salary Range: $132,000 – $152,000
Send resumes to:
Vaxcyte, Inc.
825 Industrial Road, Suite 300
San Carlos, CA 94070
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.
What We Do
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re-engineering the way highly complex immunizations are made through modern synthetic techniques, including advanced chemistry and the XpressCFᵀᴹ cell-free protein synthesis platform, exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company’s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits. Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.